Form 4: Danaher EVP Riley Receives Significant Equity Grants

Danaher Corporation's Executive Vice President, Christopher Paul Riley, received significant equity grants including restricted stock units and stock options.

Summary

• Christopher Paul Riley, Executive Vice President of Danaher Corporation, was granted 6,172 restricted stock units (RSUs) on March 1, 2026.
• These RSUs are payable solely in common stock and will vest 25% annually over four years, starting from the grant date.
• Riley also received 16,681 employee stock options with an exercise price of $210.64, exercisable 50% on the third and fourth anniversaries of the March 1, 2026 grant date, and expiring on March 1, 2036.
• A disposition of 1,115 shares of common stock occurred at a price of $210.64, likely related to tax withholding for equity compensation.
• Following these transactions, Riley beneficially owns 20,400 shares of common stock and 16,681 employee stock options.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing positively as it reflects routine executive compensation, aligning management's long-term interests with shareholder value through equity grants, which is a healthy sign of executive retention and incentive structure.

Positives

• Grant of 6,172 restricted stock units (RSUs) to a key executive, aligning management's interests with shareholder value.
• Grant of 16,681 employee stock options, providing long-term incentive for the executive.
• The grants demonstrate the company's commitment to retaining and incentivizing its executive leadership.

Negatives

• Disposition of 1,115 shares of common stock, potentially for tax obligations, reduces the executive's direct shareholding, though this is a common practice.

Future Outlook

The equity grants, particularly the multi-year vesting schedules for RSUs and options, indicate a long-term incentive strategy for executive retention and performance alignment, suggesting an expectation of continued growth and value creation over several years.

Industry Context

StockSavvy.ai notes that executive equity grants are a standard practice across industries, particularly in large, established companies like Danaher, to align executive incentives with long-term shareholder value. The structure of these grants, with multi-year vesting, is typical for retaining key talent in competitive sectors.

Comparison to Industry Standards

• The multi-year vesting schedule for RSUs (25% annually over four years) is a common structure for executive compensation in large-cap companies, comparable to practices at peers like Thermo Fisher Scientific (TMO) or Abbott Laboratories (ABT), which also use similar long-term incentive plans to retain executives.
• The stock option grant with a 3-4 year exercisability period and a 10-year expiration is also standard for executive compensation, aiming to incentivize sustained performance over a significant timeframe, aligning with best practices seen in the healthcare and industrial technology sectors.

Stakeholder Impact

• Shareholders: The equity grants align the executive's financial interests with long-term shareholder value creation, potentially leading to more focused management decisions aimed at stock price appreciation.
• Employees: May signal stability in executive leadership and a commitment to competitive compensation practices.

Next Steps

• Vesting of 25% of restricted stock units on March 1, 2027, March 1, 2028, March 1, 2029, and March 1, 2030.
• Employee stock options become 50% exercisable on March 1, 2029, and the remaining 50% on March 1, 2030.

Key Dates

Recommendation

This Form 4 filing details routine executive equity compensation and does not provide new information that would fundamentally alter the investment thesis for Danaher. It reflects standard practices for executive incentives, which is generally a neutral to slightly positive signal for long-term alignment, but not a catalyst for a strong buy or sell recommendation.

Keywords

Danaher, DHR, SEC Form 4, Insider Trading, Equity Grant, Restricted Stock Units, Stock Options, Executive Compensation, Christopher Paul Riley